Risks versus benefits of valproic acid?
Ashadeep
A
Chandrareddy
Ozgul
O
Muneyyirci-Delale
D015096:3-Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors; D000700:Analgesics / Q000009:adverse effects*; D004715:Endometriosis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D017588:Hyperandrogenism / Q000139:chemically induced; D008597:Menstrual Cycle / Q000187:drug effects; D017699:Pelvic Pain / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D011372:Progestins / Q000627:therapeutic use; D012107:Research Design; D018570:Risk Assessment; D016896:Treatment Outcome; D014635:Valproic Acid / Q000009:adverse effects*
D000700:Analgesics; D004791:Enzyme Inhibitors; D011372:Progestins; D014635:Valproic Acid; D015096:3-Hydroxysteroid Dehydrogenases